Evidence map›Paper›PMID 41179734›Full record

ReviewWorld journal of hepatology2025

Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis.

Wen-Long He, Shuai Yan, Jia-Jie Lu, Lin Chen, Jin-Zhu Wu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wen-Long HeDepartment of Hepatobiliary Surgery, Nantong Third People's Hospital, Nantong 226300, Jiangsu Province, China.
Shuai YanDepartment of Hepatobiliary Surgery, Nantong Third People's Hospital, Nantong 226300, Jiangsu Province, China.
Jia-Jie LuDepartment of Hepatobiliary Surgery, Nantong Third People's Hospital, Nantong 226300, Jiangsu Province, China.
Lin ChenInstitute of Liver Diseases, Affiliated Nantong Hospital Three of Nantong University, Nantong 226300, Jiangsu Province, China.
Jin-Zhu WuDepartment of Hepatobiliary Surgery, Nantong Third People's Hospital, Nantong 226300, Jiangsu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal vein thrombosis (PVT) is one of the most common serious complications in patients with liver cirrhosis. The occurrence of PVT not only aggravates the condition of liver cirrhosis but can also cause several serious complications, such as portal hypertension, esophagogastric variceal bleeding, and refractory ascites. All these factors have a serious impact on patients' quality of life and prognosis. This article evaluates the current evidence on the management of PVT in cirrhosis and explores the role of direct oral anticoagulants, but data on individualized anticoagulation strategies are limited and lacking for the treatment of PVT in cirrhosis, and it is hoped that it will inform a broad range of clinicians on the treatment of cirrhosis combined with PVT.

Indexed as

AnticoagulationDirect-acting oral anticoagulantsEdoxabanLiver cirrhosisPortal hypertensionPortal vein thrombosisThrombolysis

Identifiers

PMID41179734
PMCPMC12576734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.